Derma Sciences Cmn (DSCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,100 | -2,339 | 22 | 61 | 192 |
| Depreciation Amortization | 1,557 | 526 | 311 | 169 | 197 |
| Accounts receivable | 159 | 164 | -507 | 164 | 537 |
| Accounts payable and accrued liabilities | -158 | 470 | -7 | -287 | -426 |
| Other Working Capital | 603 | 149 | -1,471 | 405 | 94 |
| Other Operating Activity | 1,896 | -95 | 737 | 323 | 224 |
| Operating Cash Flow | $2,958 | $-1,124 | $-915 | $837 | $818 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -189 | -1,031 | -86 | -85 | -39 |
| Net Acquisitions | -49 | -1,943 | N/A | -1,048 | N/A |
| Purchase Sale Intangibles | N/A | N/A | -115 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -115 | 0 | 0 |
| Investing Cash Flow | $-239 | $-2,973 | $-200 | $-1,133 | $-39 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -1,682 | 1,349 | -824 | 663 | -640 |
| Debt Issued | N/A | N/A | 1,127 | N/A | -38 |
| Debt Repayment | -446 | -210 | -196 | -51 | N/A |
| Common Stock Issued | 522 | 2,661 | N/A | 753 | N/A |
| Other Financing Activity | -117 | -92 | -29 | -98 | 0 |
| Financing Cash Flow | $-1,723 | $3,708 | $78 | $1,267 | $-678 |
| Exchange Rate Effect | 63 | -4 | -19 | 0 | N/A |
| Beginning Cash Position | 47 | 440 | 1,496 | 525 | 424 |
| End Cash Position | 1,105 | 47 | 440 | 1,496 | 525 |
| Net Cash Flow | $1,059 | $-393 | $-1,057 | $972 | $101 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,958 | -1,124 | -915 | 837 | 818 |
| Capital Expenditure | -224 | -1,031 | -86 | -85 | -39 |
| Free Cash Flow | 2,734 | -2,155 | -1,001 | 752 | 779 |